# 2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA)

> **NCT03281837** · NA · COMPLETED · sponsor: **Fidia Pharma USA Inc.** · enrollment: 148 (actual)

## Conditions studied

- Osteoarthritis, Knee
- Knee Osteoarthritis
- Patellofemoral Osteoarthritis

## Interventions

- **DEVICE:** HYMOVIS plus Physical Exercise Program (PEP)
- **OTHER:** Physical Exercise Program (PEP) alone

## Key facts

- **NCT ID:** NCT03281837
- **Lead sponsor:** Fidia Pharma USA Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-01
- **Primary completion:** 2020-07-09
- **Final completion:** 2020-07-16
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2020-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03281837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03281837, "2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03281837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*